Erratum
Published in:
Transfuze Hematol. dnes,31, 2025, No. 4, p. 334-335.
Category:
Autoři a redakce časopisu se tímto omlouvají čtenářům za chyby v článku Antitrombotické zajištění žen v průběhu těhotenství, kolem porodu a v šestinedělí otištěného v 3. letošním čísle Transfuze a hematologie dnes (Transfuze Hematol Dnes 2025; 31 (3) : 199 – 204) , které vznikly při převzetí doporučení z jiného periodika. Níže uveřejňujeme opravené části článku.
Děkujeme za pochopení a děkujeme zvlášť panu doktorovi Pavlu Polákovi za upozornění na tyto nedostatky.
Redakce Transfuze a hematologie dnes
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2025 Issue 4
- Impact of Prophylaxis on Reducing the Risk of Neurological Problems Associated with Bleeding in Hemophilia A
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
-
All articles in this issue
- Generational shift of the treatment of classical Hodgkin lymphoma
- Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025
- CAR-T lymphocytes in lymphoma treatment
- Modern therapeutic approaches in the treatment of relapsed and refractory marginal zone lymphoma
- Follicular lymphoma – current perspective on treatment with emphasis on chemo free strategies
- Treatment of relapsed/refractory diffuse large B-cell lymphoma and the real-world data perspective
- Early isolated central nervous system relapse of mantle cell lymphoma successfully treated with ibrutinib and CAR T-cell therapy
- Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia – consensus of expert panel from certified centres in Czechia and Slovakia for 2025
- Transfusion and Haematology Today
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia – consensus of expert panel from certified centres in Czechia and Slovakia for 2025
- Generational shift of the treatment of classical Hodgkin lymphoma
- CAR-T lymphocytes in lymphoma treatment
- Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025